| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2016 | 2018 | |||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
CCNT2 antisense RNA 1 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
long intergenic non-protein coding RNA 894 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
long intergenic non-protein coding RNA 649 | 0.931 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1968 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
RAB4B-EGLN2 readthrough (NMD candidate) | 0.641 | 0.654 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
LIPC antisense RNA 1 | 0.839 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
serous ovarian cancer associated RNA | 0.821 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
MECOM antisense RNA 1 | 0.931 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
cytochrome P450 family 2 subfamily F member 2, pseudogene |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
testis expressed 41 | 0.743 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
VLDLR antisense RNA 1 | 0.821 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
cation channel sperm associated 2 pseudogene 1 | 0.931 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | |||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
stabilin 1 | 0.619 | 0.692 | 8.7E-50 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
dynein axonemal heavy chain 2 | 0.931 | 0.115 | 1.3E-44 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ATP binding cassette subfamily A member 6 | 0.861 | 0.231 | 5.1E-27 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
solute carrier family 34 member 1 | 0.619 | 0.423 | 8.9E-27 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
HYDIN axonemal central pair apparatus protein | 0.641 | 0.538 | 2.3E-24 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
testis expressed 9 | 0.839 | 0.154 | 6.4E-22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
serine/threonine kinase 36 | 0.678 | 0.577 | 7.1E-22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
meiosis specific nuclear structural 1 | 0.890 | 0.077 | 2.1E-21 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 |